Ménière’s Disease: Treatment Options, Dietary Restrictions, and Lifestyle Modifications [PDF]
Journal of Pharmacy and Bioallied SciencesThis review aims to review treatments and studies for Ménière’s disease (MD) and the impact of dietary restrictions and lifestyle changes on MD symptoms.
Sahil Kongala
doaj +2 more sources
Intratympanic corticosteroids in Ménière's disease: A mini-review
Journal of Otology, 2017 This article reviews the effectiveness of intratympanic corticosteroids for vertigo control in Ménière's disease at 2-years follow-up according to the guidelines expressed by the American Academy of Otolaryngology-Head & Neck Surgery.
Mitesh Patel
exaly +3 more sources
Intratympanic injection of human umbilical cord mesenchymal stem cell derived small extracellular vesicles for refractory sudden sensorineural hearing loss: a Phase 1 trial [PDF]
Stem Cell Research & TherapyBackground Refractory sudden sensorineural hearing loss (RSSNHL) remains a therapeutic challenge with limited effective treatment options. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles (hucMSC-sEVs) have demonstrated ...
Fan Shu +9 more
doaj +2 more sources
Multimodal Audiovestibular Assessment After Intratympanic Gentamicin for Vestibular Drop Attacks in Ménière’s Disease: A Case Report and Focused Review [PDF]
DiagnosticsBackground and Clinical Significance: Vestibular drop attacks are a rare but disabling manifestation of Ménière’s disease. This study aimed to demonstrate the value of multimodal audiovestibular assessment in documenting vestibular deficit after ...
Gabriela Cornelia Musat +4 more
doaj +2 more sources
Optimal Timing of Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Mini-Review [PDF]
Medeniyet Medical JournalIdiopathic sudden sensorineural hearing loss (ISSNHL) is an otologic emergency. While systemic corticosteroids are first-line therapy, intratympanic corticosteroid (ITC) injection has emerged as an important modality. The optimal timing of ITC—as primary
Sidian YAO +4 more
doaj +2 more sources
Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone [PDF]
Hematology ReportsBackground: Bortezomib, a proteasome inhibitor used in multiple myeloma (MM), is associated with several adverse effects, most notably peripheral neuropathy. Ototoxicity, however, remains a rare and underrecognized complication.
Natalia Peláez Casillas +4 more
doaj +2 more sources
Role of Transtympanic Steroid in Sudden Sensorineural Hearing Loss: A Retrospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Sudden Sensorineural Hearing Loss (SNHL) is medical emergency in otology. The diagnosis and treatment of sudden SNHL remains a matter of discussion as no single treatment is gold standard. Antivirals, systemic and intratympanic steroids,
Vinish Kumar Agarwal +4 more
doaj +1 more source
Intratympanic Steroid for the Management of Sudden Hearing Loss: Introduction of a Tapering Method [PDF]
Iranian Journal of Otorhinolaryngology, 2022 Introduction:Sudden sensorineural hearing loss (SSNHL) is a therapeutic challenge. There are several controversies regarding the management protocol of SSNHL.
Mohsen Rajati +5 more
doaj +1 more source
Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss [PDF]
Iranian Journal of Otorhinolaryngology, 2021 Introduction: Oral prednisolone was suggested as the first step to treat idiopathic sudden sensorineural hearing loss (ISSHL). This study aimed to investigate the effect of pulse therapy with methylprednisolone and intratympanic methylprednisolone ...
Maryam Amizadeh +3 more
doaj +1 more source
Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis [PDF]
Clinical and Experimental Otorhinolaryngology, 2022 Objectives Intratympanic dexamethasone injection (ITDI) has been introduced as a treatment option for subjective tinnitus. However, the effects of ITDI on patients with tinnitus remain unclear.
Juyong Chung +3 more
doaj +1 more source